The Role of Chitinase-3-like Protein-1 (YKL40) in the Therapy of Cancer and Other Chronic-Inflammation-Related Diseases
Pharmaceuticals · 27.02.2024 · 17 (3) · 307
DOI: 10.3390/ph17030307 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 27.02.2024. Verfasst von Ming-Cheng Chang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Isotope Research Application, National Atomic Research Institute, P.O. Box 3-27, Longtan, Taoyuan 325, Taiwan. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council of Taiwan.
Abstract (Originalsprache)
Chitinase-3-like protein-1 (CHI3L1), also known as YKL40, is a glycoprotein that belongs to the chitinase protein family. It is involved in various biological functions, including cell proliferation and tissue remodeling, with inflammatory and immunomodulatory capabilities. Several studies have shown that CHI3L1(YKL40) is upregulated in various diseases, such as cancer, asthma, and inflammatory bowel disease, among others. Although the expression level of CHI3L1(YKL40) is associated with disease activity, severity, and prognosis, its potential as a therapeutic target is still under investigation. In this review, we summarize the biological functions, pathological roles, and potential clinical applications of specific inhibitors and targeted therapies related to CHI3L1(YKL40).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Isotope Research Application, National Atomic Research Institute, P.O. Box 3-27, Longtan, Taoyuan 325, Taiwan.
- Department of Obstetrics and Gynecology, College of Medicine, National Taiwan University, Taipei 100226, Taiwan.
- Department of Obstetrics and Gynecology, National Taiwan University Hospital, Taipei 100226, Taiwan.
ORCID-Profile: Ying-Cheng Chiang
Förderung
- National Science and Technology Council of Taiwan
Zitieren
APA
Chang, M. C., Chen, C. T., Chiang, P. F., & Chiang, Y. C. (2024). The Role of Chitinase-3-like Protein-1 (YKL40) in the Therapy of Cancer and Other Chronic-Inflammation-Related Diseases. Pharmaceuticals, 17(3), 307. https://doi.org/10.3390/ph17030307
Vancouver
Chang MC, Chen CT, Chiang PF, Chiang YC. The Role of Chitinase-3-like Protein-1 (YKL40) in the Therapy of Cancer and Other Chronic-Inflammation-Related Diseases. Pharmaceuticals. 2024;17(3):307. doi:10.3390/ph17030307
BibTeX
@article{Chang2024,
author = {Chang, Ming-Cheng and Chen, Chun-Tang and Chiang, Ping-Fang and Chiang, Ying-Cheng},
title = {The Role of Chitinase-3-like Protein-1 (YKL40) in the Therapy of Cancer and Other Chronic-Inflammation-Related Diseases},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {3},
pages = {307},
doi = {10.3390/ph17030307}
}
EUVIMED